 | • レポートコード：D0GIR-00701 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、β-インターフェロンの世界市場を広く調査・分析し、今後の市場展望をまとめております。β-インターフェロンの種類別市場規模（注射、局所）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Hainan Unipul Pharmaceutical、Anke Bio、Roche、Kawin、SP (Brinny) Company、Amoytop Biotech、Kexing Biopharm、Sinopharm、Tri-Prime Gene、Changchun Institute of Biological Products ・地域別グローバル市場分析 2015年-2020年 ・β-インターフェロンの北米市場（アメリカ、カナダ、メキシコ） ・β-インターフェロンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・β-インターフェロンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・β-インターフェロンの南米市場（ブラジル、アルゼンチン） ・β-インターフェロンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、局所 ・用途別分析：病院、クリニック、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The β-Interferon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global β-Interferon sales will be xx in 2020 from β-Interferon million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global β-Interferon market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the β-Interferon industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on β-Interferon and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
β-Interferon market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, β-Interferon market has been segmented into:
Injection
Topical
By Application, β-Interferon has been segmented into:
Hospital
Clinics
Drug Store
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global β-Interferon market presented in the report. This section sheds light on the sales growth of different regional and country-level β-Interferon markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global β-Interferon market.
The report offers in-depth assessment of the growth and other aspects of the β-Interferon market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and β-Interferon Market Share Analysis
β-Interferon competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, β-Interferon sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the β-Interferon sales, revenue and market share for each player covered in this report.
The major players covered in β-Interferon are:
Merck
Hainan Unipul Pharmaceutical
Anke Bio
Roche
Kawin
SP (Brinny) Company
Amoytop Biotech
Kexing Biopharm
Sinopharm
Tri-Prime Gene
Changchun Institute of Biological Products
Among other players domestic and global, β-Interferon market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 β-Interferon Market Overview
1.1 Product Overview and Scope of β-Interferon
1.2 Classification of β-Interferon by Type
1.2.1 Global β-Interferon Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global β-Interferon Revenue Market Share by Type in 2019
1.2.3 Injection
1.2.4 Topical
1.3 Global β-Interferon Market by Application
1.3.1 Overview: Global β-Interferon Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Global β-Interferon Market by Regions
1.4.1 Global β-Interferon Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of β-Interferon (2015-2025)
1.4.3 North America (USA, Canada and Mexico) β-Interferon Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) β-Interferon Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) β-Interferon Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) β-Interferon Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) β-Interferon Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: β-Interferon Industry Impact
1.5.1 COVID-19 Potential Implications for the β-Interferon
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on β-Interferon
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hainan Unipul Pharmaceutical
2.2.1 Hainan Unipul Pharmaceutical Details
2.2.2 Hainan Unipul Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hainan Unipul Pharmaceutical SWOT Analysis
2.2.4 Hainan Unipul Pharmaceutical Product and Services
2.2.5 Hainan Unipul Pharmaceutical β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.3 Anke Bio
2.3.1 Anke Bio Details
2.3.2 Anke Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Anke Bio SWOT Analysis
2.3.4 Anke Bio Product and Services
2.3.5 Anke Bio β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kawin
2.5.1 Kawin Details
2.5.2 Kawin Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kawin SWOT Analysis
2.5.4 Kawin Product and Services
2.5.5 Kawin β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.6 SP (Brinny) Company
2.6.1 SP (Brinny) Company Details
2.6.2 SP (Brinny) Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 SP (Brinny) Company SWOT Analysis
2.6.4 SP (Brinny) Company Product and Services
2.6.5 SP (Brinny) Company β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amoytop Biotech
2.7.1 Amoytop Biotech Details
2.7.2 Amoytop Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amoytop Biotech SWOT Analysis
2.7.4 Amoytop Biotech Product and Services
2.7.5 Amoytop Biotech β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.8 Kexing Biopharm
2.8.1 Kexing Biopharm Details
2.8.2 Kexing Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Kexing Biopharm SWOT Analysis
2.8.4 Kexing Biopharm Product and Services
2.8.5 Kexing Biopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sinopharm
2.9.1 Sinopharm Details
2.9.2 Sinopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sinopharm SWOT Analysis
2.9.4 Sinopharm Product and Services
2.9.5 Sinopharm β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.10 Tri-Prime Gene
2.10.1 Tri-Prime Gene Details
2.10.2 Tri-Prime Gene Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Tri-Prime Gene SWOT Analysis
2.10.4 Tri-Prime Gene Product and Services
2.10.5 Tri-Prime Gene β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
2.11 Changchun Institute of Biological Products
2.11.1 Changchun Institute of Biological Products Details
2.11.2 Changchun Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Changchun Institute of Biological Products SWOT Analysis
2.11.4 Changchun Institute of Biological Products Product and Services
2.11.5 Changchun Institute of Biological Products β-Interferon Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global β-Interferon Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 β-Interferon Players Market Share
3.2.2 Top 10 β-Interferon Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global β-Interferon Revenue and Market Share by Regions
4.2 North America β-Interferon Revenue and Growth Rate (2015-2020)
4.3 Europe β-Interferon Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific β-Interferon Revenue and Growth Rate (2015-2020)
4.5 South America β-Interferon Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa β-Interferon Revenue and Growth Rate (2015-2020)
5 North America β-Interferon Revenue by Countries
5.1 North America β-Interferon Revenue by Countries (2015-2020)
5.2 USA β-Interferon Revenue and Growth Rate (2015-2020)
5.3 Canada β-Interferon Revenue and Growth Rate (2015-2020)
5.4 Mexico β-Interferon Revenue and Growth Rate (2015-2020)
6 Europe β-Interferon Revenue by Countries
6.1 Europe β-Interferon Revenue by Countries (2015-2020)
6.2 Germany β-Interferon Revenue and Growth Rate (2015-2020)
6.3 UK β-Interferon Revenue and Growth Rate (2015-2020)
6.4 France β-Interferon Revenue and Growth Rate (2015-2020)
6.5 Russia β-Interferon Revenue and Growth Rate (2015-2020)
6.6 Italy β-Interferon Revenue and Growth Rate (2015-2020)
7 Asia-Pacific β-Interferon Revenue by Countries
7.1 Asia-Pacific β-Interferon Revenue by Countries (2015-2020)
7.2 China β-Interferon Revenue and Growth Rate (2015-2020)
7.3 Japan β-Interferon Revenue and Growth Rate (2015-2020)
7.4 Korea β-Interferon Revenue and Growth Rate (2015-2020)
7.5 India β-Interferon Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia β-Interferon Revenue and Growth Rate (2015-2020)
8 South America β-Interferon Revenue by Countries
8.1 South America β-Interferon Revenue by Countries (2015-2020)
8.2 Brazil β-Interferon Revenue and Growth Rate (2015-2020)
8.3 Argentina β-Interferon Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue β-Interferon by Countries
9.1 Middle East & Africa β-Interferon Revenue by Countries (2015-2020)
9.2 Saudi Arabia β-Interferon Revenue and Growth Rate (2015-2020)
9.3 UAE β-Interferon Revenue and Growth Rate (2015-2020)
9.4 Egypt β-Interferon Revenue and Growth Rate (2015-2020)
9.5 South Africa β-Interferon Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global β-Interferon Revenue and Market Share by Type (2015-2020)
10.2 Global β-Interferon Market Forecast by Type (2019-2024)
10.3 Injection Revenue Growth Rate (2015-2025)
10.4 Topical Revenue Growth Rate (2015-2025)
11 Global β-Interferon Market Segment by Application
11.1 Global β-Interferon Revenue Market Share by Application (2015-2020)
11.2 β-Interferon Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Drug Store Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global β-Interferon Market Size Forecast (2021-2025)
12.1 Global β-Interferon Market Size Forecast (2021-2025)
12.2 Global β-Interferon Market Forecast by Regions (2021-2025)
12.3 North America β-Interferon Revenue Market Forecast (2021-2025)
12.4 Europe β-Interferon Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific β-Interferon Revenue Market Forecast (2021-2025)
12.6 South America β-Interferon Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa β-Interferon Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global β-Interferon Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of β-Interferon by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global β-Interferon Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market β-Interferon Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global β-Interferon Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck Corporate Information, Location and Competitors
Table 7. Merck β-Interferon Major Business
Table 8. Merck β-Interferon Total Revenue (USD Million) (2017-2018)
Table 9. Merck SWOT Analysis
Table 10. Merck β-Interferon Product and Solutions
Table 11. Merck β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Hainan Unipul Pharmaceutical Corporate Information, Location and Competitors
Table 13. Hainan Unipul Pharmaceutical β-Interferon Major Business
Table 14. Hainan Unipul Pharmaceutical β-Interferon Total Revenue (USD Million) (2018-2019)
Table 15. Hainan Unipul Pharmaceutical SWOT Analysis
Table 16. Hainan Unipul Pharmaceutical β-Interferon Product and Solutions
Table 17. Hainan Unipul Pharmaceutical β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Anke Bio Corporate Information, Location and Competitors
Table 19. Anke Bio β-Interferon Major Business
Table 20. Anke Bio β-Interferon Total Revenue (USD Million) (2017-2018)
Table 21. Anke Bio SWOT Analysis
Table 22. Anke Bio β-Interferon Product and Solutions
Table 23. Anke Bio β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Corporate Information, Location and Competitors
Table 25. Roche β-Interferon Major Business
Table 26. Roche β-Interferon Total Revenue (USD Million) (2017-2018)
Table 27. Roche SWOT Analysis
Table 28. Roche β-Interferon Product and Solutions
Table 29. Roche β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Kawin Corporate Information, Location and Competitors
Table 31. Kawin β-Interferon Major Business
Table 32. Kawin β-Interferon Total Revenue (USD Million) (2017-2018)
Table 33. Kawin SWOT Analysis
Table 34. Kawin β-Interferon Product and Solutions
Table 35. Kawin β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. SP (Brinny) Company Corporate Information, Location and Competitors
Table 37. SP (Brinny) Company β-Interferon Major Business
Table 38. SP (Brinny) Company β-Interferon Total Revenue (USD Million) (2017-2018)
Table 39. SP (Brinny) Company SWOT Analysis
Table 40. SP (Brinny) Company β-Interferon Product and Solutions
Table 41. SP (Brinny) Company β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Amoytop Biotech Corporate Information, Location and Competitors
Table 43. Amoytop Biotech β-Interferon Major Business
Table 44. Amoytop Biotech β-Interferon Total Revenue (USD Million) (2017-2018)
Table 45. Amoytop Biotech SWOT Analysis
Table 46. Amoytop Biotech β-Interferon Product and Solutions
Table 47. Amoytop Biotech β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Kexing Biopharm Corporate Information, Location and Competitors
Table 49. Kexing Biopharm β-Interferon Major Business
Table 50. Kexing Biopharm β-Interferon Total Revenue (USD Million) (2017-2018)
Table 51. Kexing Biopharm SWOT Analysis
Table 52. Kexing Biopharm β-Interferon Product and Solutions
Table 53. Kexing Biopharm β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sinopharm Corporate Information, Location and Competitors
Table 55. Sinopharm β-Interferon Major Business
Table 56. Sinopharm β-Interferon Total Revenue (USD Million) (2017-2018)
Table 57. Sinopharm SWOT Analysis
Table 58. Sinopharm β-Interferon Product and Solutions
Table 59. Sinopharm β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Tri-Prime Gene Corporate Information, Location and Competitors
Table 61. Tri-Prime Gene β-Interferon Major Business
Table 62. Tri-Prime Gene β-Interferon Total Revenue (USD Million) (2017-2018)
Table 63. Tri-Prime Gene SWOT Analysis
Table 64. Tri-Prime Gene β-Interferon Product and Solutions
Table 65. Tri-Prime Gene β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Changchun Institute of Biological Products Corporate Information, Location and Competitors
Table 67. Changchun Institute of Biological Products β-Interferon Major Business
Table 68. Changchun Institute of Biological Products β-Interferon Total Revenue (USD Million) (2017-2018)
Table 69. Changchun Institute of Biological Products SWOT Analysis
Table 70. Changchun Institute of Biological Products β-Interferon Product and Solutions
Table 71. Changchun Institute of Biological Products β-Interferon Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global β-Interferon Revenue (Million USD) by Players (2015-2020)
Table 73. Global β-Interferon Revenue Share by Players (2015-2020)
Table 74. Global β-Interferon Revenue (Million USD) by Regions (2015-2020)
Table 75. Global β-Interferon Revenue Market Share by Regions (2015-2020)
Table 76. North America β-Interferon Revenue by Countries (2015-2020)
Table 77. North America β-Interferon Revenue Market Share by Countries (2015-2020)
Table 78. Europe β-Interferon Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific β-Interferon Revenue (Million USD) by Countries (2015-2020)
Table 80. South America β-Interferon Revenue by Countries (2015-2020)
Table 81. South America β-Interferon Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa β-Interferon Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa β-Interferon Revenue Market Share by Countries (2015-2020)
Table 84. Global β-Interferon Revenue (Million USD) by Type (2015-2020)
Table 85. Global β-Interferon Revenue Share by Type (2015-2020)
Table 86. Global β-Interferon Revenue Forecast by Type (2021-2025)
Table 87. Global β-Interferon Revenue by Application (2015-2020)
Table 88. Global β-Interferon Revenue Share by Application (2015-2020)
Table 89. Global β-Interferon Revenue Forecast by Application (2021-2025)
Table 90. Global β-Interferon Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. β-Interferon Picture
Figure 2. Global β-Interferon Revenue Market Share by Type in 2019
Figure 3. Injection Picture
Figure 4. Topical Picture
Figure 5. β-Interferon Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Drug Store Picture
Figure 9. Others Picture
Figure 10. Global β-Interferon Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global β-Interferon Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global β-Interferon Revenue Share by Players in 2019
Figure 18. Global Top 5 Players β-Interferon Revenue Market Share in 2019
Figure 19. Global Top 10 Players β-Interferon Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global β-Interferon Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global β-Interferon Revenue Market Share by Regions (2015-2020)
Figure 23. Global β-Interferon Revenue Market Share by Regions in 2018
Figure 24. North America β-Interferon Revenue and Growth Rate (2015-2020)
Figure 25. Europe β-Interferon Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific β-Interferon Revenue and Growth Rate (2015-2020)
Figure 27. South America β-Interferon Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa β-Interferon Revenue and Growth Rate (2015-2020)
Figure 29. North America β-Interferon Revenue Market Share by Countries (2015-2020)
Figure 30. North America β-Interferon Revenue Market Share by Countries in 2019
Figure 31. USA β-Interferon Revenue and Growth Rate (2015-2020)
Figure 32. Canada β-Interferon Revenue and Growth Rate (2015-2020)
Figure 33. Mexico β-Interferon Revenue and Growth Rate (2015-2020)
Figure 34. Europe β-Interferon Revenue Market Share by Countries (2015-2020)
Figure 35. Europe β-Interferon Revenue Market Share by Countries in 2019
Figure 36. Germany β-Interferon Revenue and Growth Rate (2015-2020)
Figure 37. UK β-Interferon Revenue and Growth Rate (2015-2020)
Figure 38. France β-Interferon Revenue and Growth Rate (2015-2020)
Figure 39. Russia β-Interferon Revenue and Growth Rate (2015-2020)
Figure 40. Italy β-Interferon Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific β-Interferon Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific β-Interferon Revenue Market Share by Countries in 2019
Figure 43. China β-Interferon Revenue and Growth Rate (2015-2020)
Figure 44. Japan β-Interferon Revenue and Growth Rate (2015-2020)
Figure 45. Korea β-Interferon Revenue and Growth Rate (2015-2020)
Figure 46. India β-Interferon Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia β-Interferon Revenue and Growth Rate (2015-2020)
Figure 48. South America β-Interferon Revenue Market Share by Countries (2015-2020)
Figure 49. South America β-Interferon Revenue Market Share by Countries in 2019
Figure 50. Brazil β-Interferon Revenue and Growth Rate (2015-2020)
Figure 51. Argentina β-Interferon Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa β-Interferon Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa β-Interferon Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia β-Interferon Revenue and Growth Rate (2015-2020)
Figure 55. UAE β-Interferon Revenue and Growth Rate (2015-2020)
Figure 56. Egypt β-Interferon Revenue and Growth Rate (2015-2020)
Figure 57. South Africa β-Interferon Revenue and Growth Rate (2015-2020)
Figure 58. Global β-Interferon Revenue Share by Type (2015-2020)
Figure 59. Global β-Interferon Revenue Share by Type in 2019
Figure 60. Global β-Interferon Market Share Forecast by Type (2021-2025)
Figure 61. Global Injection Revenue Growth Rate (2015-2020)
Figure 62. Global Topical Revenue Growth Rate (2015-2020)
Figure 63. Global β-Interferon Revenue Share by Application (2015-2020)
Figure 64. Global β-Interferon Revenue Share by Application in 2019
Figure 65. Global β-Interferon Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Drug Store Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global β-Interferon Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global β-Interferon Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global β-Interferon Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America β-Interferon Revenue Market Forecast (2021-2025)
Figure 74. Europe β-Interferon Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific β-Interferon Revenue Market Forecast (2021-2025)
Figure 76. South America β-Interferon Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa β-Interferon Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
ヒトインターフェロンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Interferons market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- ペグ化タンパク質治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global PEGylated Protein Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 11600 million by 2025, from USD 10010 million in 2019. The PEGylat…
- 結核感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Tuberculosis Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- バイオシミラー/生物学的製剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biosimilars/follow-on-biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10730 million by 2025, from USD 9560.2 million in 2019. The Biosi…
- 結核検査・診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Tuberculosis Testing and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…